Fig. 1.
Serum levels of IL-33 before immunotherapy (ITA) and after the first course of immunotherapy (ITA-II) and in controls (median and total ranges). Only significant differences are shown
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.